Stock Events

Stock Events

Achilles Therapeutics (ACHL) Q3 2023 Earnings

13NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.61

-0.54

-0.47

-0.4

Details

Expected EPS

-0.4

Actual EPS

-0.42

Surprise EPS

-0.02

Surprise Percent

+5%

Description

Achilles Therapeutics (ACHL) has reported earnings of -0.42 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.